← Back to Search

Yeast Fermentate

EpiCor for Respiratory Symptoms

N/A

Waitlist Available

Led By David Crowley, MD

Research Sponsored by Cargill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 42 and 84 days

Awards & highlights

Study Summary

This trial will compare the effects of a daily supplement called EpiCor to a placebo pill on the number of cold or flu symptoms experienced by kids aged 4-12.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 42 and 84 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 42 and 84 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 42 and 84 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of cold or flu symptoms

Secondary outcome measures

Duration of cold or flu symptoms

Incidence on cold or flu symptoms from baseline to day 42

Number of days prior to first cold or flu symptoms

+10 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: EpiCorExperimental Treatment1 Intervention

500 mg EpiCor given as two gummy supplements. Participants will be instructed to take two gummies per day in the morning, with or without food, for 84 days, starting on Day 1.

Group II: PlaceboPlacebo Group1 Intervention

Two gummy supplements. Participants will be instructed to take two gummies per day in the morning, with or without food, for 84 days, starting on Day 1.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EpiCor

2015

N/A

~340

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CargillLead Sponsor

26 Previous Clinical Trials

2,933 Total Patients Enrolled

KGK Science Inc.Industry Sponsor

78 Previous Clinical Trials

5,904 Total Patients Enrolled

David Crowley, MDPrincipal InvestigatorKGK Science

35 Previous Clinical Trials

2,497 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being enrolled currently for this experiment?

"The information shared via clinicaltrials.gov indicates that this medical study, which was first posted on September 4th 2022, is not currently recruiting participants. However, there are 5 other trials accepting enrolment at the moment."

Answered by AI

What criteria makes individuals suitable for this medical experiment?

"To qualify for this research, applicants must have noticeable signs and symptoms of the respiratory condition in question, while being between the ages 4 and 12. In total 256 participants will be admitted to this clinical trial."

Answered by AI

Is this research enrolling elderly individuals as participants?

"This trial is only open to applicants aged between 4 and 12 years old. An additional 1 study is available for minors, while senior citizens can partake in up to 4 clinical trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children

2022. "Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05492370.